You have 1 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

NF2

Showing 1 - 25 of 2,018
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Natural History Study of Patients With Neurofibromatosis Type 2

Recruiting
  • Neurofibromatosis
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Jan 25, 2023

    Advanced Lymphoma, Advanced Malignant Solid Tumor, Hematopoietic and Lymphoid Cell Tumor Trial in Philadelphia (Defactinib

    Active, not recruiting
    • Advanced Lymphoma
    • +5 more
    • Defactinib Hydrochloride
    • Philadelphia, Pennsylvania
      ECOG-ACRIN Cancer Research Group
    Jun 28, 2022

    89Zr-Bevacizumab PET/CT Imaging in NF2 Patients

    Recruiting
    • Neurofibromatosis 2
    • Bevacizumab Zirconium Zr-89
    • Leiden, Zuid-Holland, Netherlands
      Leiden University Medical Center
    Jan 5, 2023

    Solid Tumors, Adult, Solid Tumor, Mesothelioma (MPM) Trial in United States (IK-930)

    Recruiting
    • Solid Tumors, Adult
    • +7 more
    • Boston, Massachusetts
    • +6 more
    Jan 24, 2023

    Vestibular Schwannoma, Neurofibromatosis Type 2 Trial in Beijing (Icotinib)

    Completed
    • Vestibular Schwannoma
    • Neurofibromatosis Type 2
    • Beijing, Beijing, China
    • +1 more
    Sep 8, 2021

    Neurofibromatosis Type 2 Trial in United States (REC-2282, Placebo)

    Recruiting
    • Neurofibromatosis Type 2
    • Los Angeles, California
    • +11 more
    Aug 5, 2022

    Neurofibromatoses Trial in Boston (Stress and Symptom Management Program 1, Stress and Symptom Management Program 2)

    Recruiting
    • Neurofibromatoses
    • Stress and Symptom Management Program 1
    • Stress and Symptom Management Program 2
    • Boston, Massachusetts
      Massachusetts General Hospital
    Sep 7, 2021

    Neurofibromatosis Type 2, Neuroma, Acoustic Trial in Los Angeles (RAD001, everolimus)

    Active, not recruiting
    • Neurofibromatosis Type 2
    • Neuroma, Acoustic
    • RAD001, everolimus
    • Los Angeles, California
      University of California Los Angeles
    Mar 2, 2022

    Neurofibromatosis 1 (NF1), Plexiform Neurofibromas (PN) Trial run by the NCI (Selumetinib)

    Active, not recruiting
    • Neurofibromatosis 1 (NF1)
    • Plexiform Neurofibromas (PN)
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Jan 31, 2023

    Neurofibromatosis 1 and 2 (NF1 and NF2) Trial in New York (hand-held dynamometer)

    Completed
    • Neurofibromatosis 1 and 2 (NF1 and NF2)
    • hand-held dynamometer
    • New York, New York
      New York School of Medicine
    Mar 16, 2021

    Solid Tumor, Adult, Mesothelioma Trial in Australia, United States (VT3989)

    Recruiting
    • Solid Tumor, Adult
    • Mesothelioma
    • Chicago, Illinois
    • +7 more
    Oct 29, 2021

    Anatomic Stage IV Breast Cancer AJCC v8, Metastatic HER2-Negative Breast Carcinoma, Metastatic Hormone Receptor-Positive Breast

    Not yet recruiting
    • Anatomic Stage IV Breast Cancer AJCC v8
    • +2 more
    • (no location specified)
    Nov 8, 2022

    Cancer, Cancer Metastatic, BRAF V600E Trial in Indianapolis (Abemaciclib, LY3214996)

    Recruiting
    • Cancer
    • +6 more
    • Indianapolis, Indiana
      Indiana University Hospital / IU Simon Cancer Center
    Jan 12, 2023

    Neurofibromatosis 1, Neurofibromatosis 2, Schwannomatosis Trial in New York

    Recruiting
    • Neurofibromatosis 1
    • +2 more
      • New York, New York
        Children's Tumor Fundation
      Jul 29, 2021

      SOcial coNNEction in Long-Term Care Home Residents

      Recruiting
      • Dementia
        • Toronto, Ontario, Canada
        • +1 more
        May 16, 2022

        MPNST, NF1, Sarcoma Trial in United States (Selumetinib)

        Not yet recruiting
        • MPNST
        • +2 more
        • Birmingham, Alabama
        • +13 more
        Jun 29, 2022

        Neurofibromatosis 1, Plexiform Neurofibroma (PN) Trial in Worldwide (Selumetinib, Placebo)

        Recruiting
        • Neurofibromatosis 1
        • Plexiform Neurofibroma (PN)
        • Gainesville, Florida
        • +40 more
        Jan 16, 2023

        NF1, Congenital Pseudarthrosis of Tibia Trial in Australia, United States (INFUSE Bone Graft (BMP-2), Control Group)

        Terminated
        Has Results
        • NF1
        • Congenital Pseudarthrosis of Tibia
        • INFUSE Bone Graft (BMP-2)
        • Control Group
        • Birmingham, Alabama
        • +15 more
        Sep 29, 2021

        Advanced Malignant Solid Tumor, Metastatic Malignant Solid Tumor, NF1 Mutation Positive Malignant Peripheral Nerve Sheath Tumor

        Active, not recruiting
        • Advanced Malignant Solid Neoplasm
        • +3 more
        • Pharmacodynamic Study
        • Telaglenastat Hydrochloride
        • Birmingham, Alabama
        • +30 more
        Sep 1, 2022

        Vestibular Schwannoma, NF2, Neurofibromatosis 2 Trial in United States (lapatinib)

        Completed
        Has Results
        • Vestibular Schwannoma
        • +4 more
        • Los Angeles, California
        • +6 more
        Dec 22, 2020

        Internet & Social Media by People With Intellectual Disabilities

        Recruiting
        • Intellectual Disability
          • Canterbury, Kent, United Kingdom
            University of Kent
          Jun 15, 2021

          Chronic Kidney Disease, Hypertension, Diabetes Trial in Rio de Janeiro (physical exercises)

          Completed
          • Chronic Kidney Disease
          • +2 more
          • physical exercises
          • Rio de Janeiro, RJ, Brazil
            Denise Mafra
          Oct 18, 2020

          Neurofibromatosis Type 2, Progressive Vestibular Schwannomas Trial in United States (Bevacizumab)

          Completed
          Has Results
          • Neurofibromatosis Type 2
          • Progressive Vestibular Schwannomas
          • Los Angeles, California
          • +11 more
          Jan 26, 2021

          Neurofibromatoses Trial in Milwaukee (Part 1 Levulan injection, Part 1 Levulan surface application, Part 1 Levulan surface

          Completed
          Has Results
          • Neurofibromatoses
          • Part 1 Levulan injection
          • +6 more
          • Milwaukee, Wisconsin
            The Medical College of Wisconsin
          Jun 16, 2021

          Neurofibromatosis 2, Progressive Vestibular Schwannoma (VS) Trial in United States (Crizotinib)

          Active, not recruiting
          • Neurofibromatosis 2
          • Progressive Vestibular Schwannoma (VS)
          • Birmingham, Alabama
          • +16 more
          Jan 3, 2023